Lee's Pharmaceutical Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5438W1116
HKD
1.69
0.07 (4.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'17
Sep'17
Jun'17
Mar'17
Dec'16
Sep'16
Jun'16
Net Sales
258.76
275.01
248.55
226.20
231.17
248.92
224.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
258.76
275.01
248.55
226.20
231.17
248.92
224.19
Raw Material Cost
80.09
90.23
79.06
76.73
60.17
79.44
54.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.90
0.83
1.26
1.26
1.05
1.06
0.78
Selling and Distribution Expenses
105.77
91.91
91.70
83.99
80.63
91.03
92.61
Other Expenses
2.67
1.96
1.48
1.96
1.87
1.45
1.71
Total Expenditure (Excl Depreciation)
213.50
202.56
186.85
181.62
160.53
186.00
165.32
Operating Profit (PBDIT) excl Other Income
45.300000000000004
72.4
61.7
44.6
70.6
62.9
58.9
Other Income
25.44
1.70
52.26
4.79
-2.75
27.74
0.65
Operating Profit (PBDIT)
70.70
74.15
128.69
52.38
69.67
92.84
69.81
Interest
0.90
0.83
1.26
1.26
1.05
1.06
0.78
Exceptional Items
-1.62
-0.08
-47.30
-0.51
-0.68
-11.21
16.05
Gross Profit (PBDT)
178.67
184.78
169.49
149.47
171.00
169.48
169.34
Depreciation
0.00
0.00
14.52
0.00
0.00
0.00
10.29
Profit Before Tax
68.17
73.24
65.61
50.61
67.95
80.57
74.80
Tax
20.97
14.49
10.57
8.65
15.24
13.69
11.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
45.66
61.82
78.69
46.38
57.77
72.81
68.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
45.66
61.82
78.69
46.38
57.77
72.81
68.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.54
-3.08
-23.65
-4.42
-5.07
-5.94
-4.69
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
47.20
58.75
55.04
41.95
52.70
66.87
63.62
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Reserves
1,804.35
0.00
1,681.15
0.00
1,601.73
0.00
1,526.08
Earnings per share (EPS)
0.08
0.1
0.13
0.08
0.1
0.12
0.12
Diluted Earnings per share
0.08
0.1
0.13
0.08
0.1
0.12
0.12
Operating Profit Margin (Excl OI)
17.49%
26.34%
24.91%
21.04%
31.33%
26.15%
26.26%
Gross Profit Margin
26.35%
26.63%
32.24%
22.37%
29.39%
32.37%
37.95%
PAT Margin
17.65%
22.48%
31.66%
20.5%
24.99%
29.25%
30.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2017 is 11.94% vs 9.06% in Dec 2016

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2017 is -10.44% vs -12.46% in Dec 2016

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2017 is -37.43% vs 14.20% in Dec 2016

stock-summary

Interest

YoY Growth in quarter ended Dec 2017 is -10.00% vs 25.00% in Dec 2016

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2017 has fallen from Dec 2016

Compare Quarterly Results Of Lee's Pharmaceutical Holdings Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
258.76
273.44
-14.68
-5.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
258.76
273.44
-14.68
-5.37%
Raw Material Cost
80.09
219.15
-139.06
-63.45%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.90
0
0.90
Selling and Distribution Expenses
105.77
13.69
92.08
672.61%
Other Expenses
2.67
0.63
2.04
323.81%
Total Expenditure (Excl Depreciation)
213.50
239.13
-25.63
-10.72%
Operating Profit (PBDIT) excl Other Income
45.26
34.31
10.95
31.91%
Other Income
25.44
5.43
20.01
368.51%
Operating Profit (PBDIT)
70.70
32.30
38.40
118.89%
Interest
0.90
9.70
-8.80
-90.72%
Exceptional Items
-1.62
0
-1.62
Gross Profit (PBDT)
178.67
54.29
124.38
229.10%
Depreciation
0.00
61.79
-61.79
-100.00%
Profit Before Tax
68.17
26.61
41.56
156.18%
Tax
20.97
3.87
17.10
441.86%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
45.66
21.11
24.55
116.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
45.66
21.11
24.55
116.30%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
1.54
0.33
1.21
366.67%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
47.20
21.44
25.76
120.15%
Equity Capital
0
0
0.00
Face Value
0.05
0.00
0.00
Reserves
1,804.35
994.20
810.15
81.49%
Earnings per share (EPS)
0.08
0.01
0.07
700.00%
Diluted Earnings per share
0.08
0.01
0.07
700.00%
Operating Profit Margin (Excl OI)
17.49%
0%
0.00
17.49%
Gross Profit Margin
26.35%
0%
0.00
26.35%
PAT Margin
17.65%
0%
0.00
17.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 25.88 Million
in Dec 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2017 is -5.89% vs 10.62% in Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 is 11.94% vs 9.06% in Dec 2016

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.72 Million
in Dec 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2017 is -19.59% vs 6.73% in Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 is -10.44% vs -12.46% in Dec 2016

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.53 Million
in Dec 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2017 is -37.43% vs -5.24% in Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 is -37.43% vs 14.20% in Dec 2016

Quarterly - Interest
Interest 0.09 Million
in Dec 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2017 is 12.50% vs -38.46% in Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 is -10.00% vs 25.00% in Dec 2016

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.49%
in Dec 2017

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2017 has fallen from Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 has fallen from Dec 2016